Herzog Named New UC Cancer Institute Clinical Director

Thomas Herzog, MD, University of Cincinnati (UC) College of Medicine alumnus, will be the new clinical director of the UC Cancer Institute, effective Aug. 1.

He replaces Franklin Smith, MD, who is leaving to become vice-president for medical affairs at Medpace, Inc. He will remain an adjunct professor of medicine and pediatrics within the UC College of Medicine.

Herzog comes from Columbia University, where he has been the director of the division of gynecologic oncology since 2004. He will also be a faculty member within the gynecologic oncology division at UC.

Herzog graduated from the UC College of Medicine in 1986 and then completed his residency at Good Samaritan Hospital in Cincinnati in 1990 and a fellowship in gynecologic oncology at the Washington University School of Medicine, St. Louis, in 1993.

Following his training, he became a faculty member at Washington University and then director of the gynecologic oncology fellowship program until 2004, when he made the move to Columbia.

Herzog is a National Institutes of Health- and American Cancer Society-funded researcher with over 200 published manuscripts. He’s also been a member of a number of national professional societies including the American College of Surgeons, for which he is also on the elected board of governors, the American Board of Obstetrics and Gynecology and the American Society for Colposcopy and Cervical Pathology, among others.

Herzog is also editor-in-chief of the journal Gynecologic Oncology Research and Practice in addition to being the editor and on the editorial boards for a number of other peer-reviewed journals.

"I’m very excited to have Dr. Herzog as a leader within the UC Cancer Institute,” says William Barrett, MD, director of the UC Cancer Institute, chair of the department of radiation oncology and medical director for UC Health’s Barrett Cancer Center. "His qualifications and expertise will help us further our mission of excellence in clinical care with an emphasis on education and research.

"The recruitment of an individual of Dr. Herzog’s stature is wonderful for the university and for Cincinnati. Dr. Herzog will be a tremendous asset for all of us in many ways.”

Related Stories

1

6 ways starting a GLP-1 medication could affect your emotions

May 20, 2026

When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.

3

$15 million bequest supports endowed chair at UC College of Medicine

May 19, 2026

As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.